BlackRock Inc. - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 179 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 3.07 and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$29,199,385
-59.0%
6,759,117
-37.5%
0.00%
-50.0%
Q2 2023$71,238,005
+3.9%
10,810,016
+7.0%
0.00%0.0%
Q1 2023$68,571,734
-10.1%
10,098,930
-2.2%
0.00%0.0%
Q4 2022$76,313,678
-21.2%
10,326,614
+5.4%
0.00%
-33.3%
Q3 2022$96,790,000
-8.3%
9,796,633
+1.2%
0.00%0.0%
Q2 2022$105,540,000
-4.3%
9,682,578
-0.7%
0.00%0.0%
Q1 2022$110,246,000
-28.5%
9,747,619
-0.8%
0.00%
-25.0%
Q4 2021$154,158,000
-7.3%
9,825,375
+1.3%
0.00%
-20.0%
Q3 2021$166,294,000
-21.6%
9,702,122
-1.7%
0.01%
-16.7%
Q2 2021$212,230,000
+40.8%
9,866,539
-1.7%
0.01%
+50.0%
Q1 2021$150,699,000
+16.9%
10,033,270
+2.2%
0.00%0.0%
Q4 2020$128,965,000
+43.9%
9,814,597
+5.8%
0.00%
+33.3%
Q3 2020$89,626,000
-16.9%
9,278,160
-1.6%
0.00%
-25.0%
Q2 2020$107,870,000
+15.0%
9,429,230
+4.1%
0.00%
-20.0%
Q1 2020$93,809,000
-39.1%
9,054,848
-3.5%
0.01%
-16.7%
Q4 2019$154,022,000
+27.7%
9,385,881
+3.4%
0.01%
+20.0%
Q3 2019$120,579,000
-4.8%
9,079,647
+1.0%
0.01%0.0%
Q2 2019$126,636,000
-19.4%
8,987,677
+5.2%
0.01%
-28.6%
Q1 2019$157,137,000
-31.5%
8,540,148
-2.7%
0.01%
-41.7%
Q4 2018$229,272,000
+12.9%
8,774,342
-0.8%
0.01%
+33.3%
Q3 2018$202,999,000
+114.8%
8,845,222
+78.3%
0.01%
+125.0%
Q2 2018$94,506,000
+31.4%
4,960,924
+16.3%
0.00%
+33.3%
Q1 2018$71,900,000
+3.5%
4,267,002
-6.6%
0.00%0.0%
Q4 2017$69,436,000
-13.1%
4,568,159
+2.4%
0.00%
-25.0%
Q3 2017$79,867,000
+9.7%
4,461,931
-0.1%
0.00%0.0%
Q2 2017$72,824,000
+35.0%
4,467,718
+15.9%
0.00%
+33.3%
Q1 2017$53,944,000
+35862.7%
3,853,200
+40908.9%
0.00%
Q4 2016$150,000
-54.8%
9,396
-52.9%
0.00%
Q3 2016$332,000
+33.3%
19,934
-10.1%
0.00%
Q2 2016$249,000
+492.9%
22,183
+344.5%
0.00%
Q1 2016$42,000
+250.0%
4,990
+280.0%
0.00%
Q4 2015$12,000
-47.8%
1,313
-35.5%
0.00%
Q3 2015$23,000
+155.6%
2,037
+176.4%
0.00%
Q2 2015$9,0000.0%737
-21.0%
0.00%
Q1 2015$9,000
-30.8%
9330.0%0.00%
Q4 2014$13,000
+62.5%
933
+20.1%
0.00%
Q3 2014$8,000
-38.5%
7770.0%0.00%
Q2 2014$13,000
-13.3%
777
-14.3%
0.00%
Q1 2014$15,000
+36.4%
9070.0%0.00%
Q4 2013$11,000
+10.0%
9070.0%0.00%
Q3 2013$10,000
+42.9%
9070.0%0.00%
Q2 2013$7,0009070.00%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Palo Alto Investors LP 2,491,200$27,154,0002.37%
Profit Investment Management, LLC 281,890$3,071,0002.26%
Sio Capital Management, LLC 488,965$5,330,0002.00%
Zebra Capital Management LLC 14,766$161,0000.47%
Prairiewood Capital, LLC 50,165$547,0000.43%
TANG CAPITAL MANAGEMENT LLC 256,696$2,798,0000.42%
HUSSMAN STRATEGIC ADVISORS, INC. 156,000$1,700,0000.29%
GLOBEFLEX CAPITAL L P 100,843$1,099,0000.27%
Epoch Investment Partners, Inc. 2,757,646$30,059,0000.18%
EMC Capital Management 16,185$176,0000.15%
View complete list of VANDA PHARMACEUTICALS INC shareholders